A time-dependent discrimination index for survival data

Statistics in Medicine

Volumn 24, Issue 24, 2005, Pages 3927-3944

  Antolini, Laura ^a,c   Boracchi, Patrizia ^b   Biganzoli, Elia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE   (Italy)

Author keywords

Discrimination; Non parametric method; ROC analysis; Survival model; Time dependence

Indexed keywords

ESTROGEN RECEPTOR; STEROID RECEPTOR; TAMOXIFEN;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; COVARIANCE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MATHEMATICAL COMPUTING; METHODOLOGY; PREDICTION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; ROC CURVE; STATISTICAL MODEL; VALIDATION PROCESS;

BREAST NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; FORECASTING; HUMANS; ITALY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 30944433977     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2427     Document Type: Article

References (37)

1. Altman DG, Royston P. What do we mean by validating a prognostic model? Statistics in Medicine 2000; 19(4):453-473.
2. Kattan MW. Evaluating a new marker's predictive contribution. Clinical Cancer Research 2004; 10(3):822-824.
3. Schemper M. Predictive accuracy and explained variation. Statistics in Medicine 2003; 22(14):2299-2308.
4. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Annals of Internal Medicine 1999; 130(6):515-524.
5. Korn EL, Simon R. Measures of explained variation for survival data. Statistics in Medicine 1990; 9(5):487-503.
6. Schemper M, Henderson R. Predictive accuracy and explained variation in Cox regression. Biometrics 2000; 56(1):249-255.
7. Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Statistics in Medicine 1999; 18(17-18):2529-2545.
8. Schumacher M, Graf E, Gerds T. How to assess prognostic models for survival data: a case study in oncology. Methods of Information in Medicine 2003; 42(5):564-571.
9. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Statistics in Medicine 2004; 23(5):723-748.
10. Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 1996; 15(4):361-387.
11. Harrell Jr FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. Journal of the American Medical Association 1982; 247(18):2543-2546.
12. Bamber D. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. Journal of Mathematical Psychology 1975; 12:387-415.
13. Pepe MS. The Statistical Evaluation of Diagnostic Tests for Classification and Prediction. Oxford University Press: New York, 2003.
14. Brown BH, Hollander M, Korwar RM. Nonparametric tests of independence for censored data, with applications to heart transplant studies. In Reliability and Biometry, Proschan, Serfling (eds). SIAM: Philadelphia, PA, 1974; 327-354.
15. Fine JP, Ying Z, Wei LJ. On the linear transformation model for censored data. Biometrika 1998; 85:980-986.
16. Henderson R, Jones M, Stare J. Accuracy of point predictions in survival analysis. Statistics in Medicine 2001; 20(20):3083-3096.
17. Pencina MJ, D'Agostino Sr RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statistics in Medicine 2004; 23(13):2109-2123.
18. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005; 61(1):92-105.
19. Boracchi P, Biganzoli E, Marubini E. Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Computational Statistics and Data Analysis 2003; 42(1-2):243-262.
20. Coradini D, Daidone MG, Boracchi P, Biganzoli E, Oriana S, Bresciani G, Pellizzaro C, Tomasic G, Di Fronzo G, Marubini E. Time-dependent relevance of steroid receptors in breast cancer. Journal of Clinical Oncology 2000; 18(14):2702-2709.
21. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148(3):839-843.
22. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143(1):29-36.
23. Lee AJ. U-Statistics: Theory and Practice. Marcel Dekker: New York, 1990.
24. Goodman LA, Kruskal WH. Measures of Association for Cross Classification. Springer: New York, 1979.
25. Schemper M. Analyses of associations with censored data by generalized Mantel and Breslow tests and generalized Kendall correlation coefficients. Biometrical Journal. Journal of Mathematical Methods in Biosciences 1984; 26:309-318.
26. Antolini L, Nam BH, D'Agostino Sr RB. Inference on correlated discrimination measures in survival analysis: nonparametric approach. Communications in Statistics: Theory and Methods 2004; 33(9):2117-2135.
27. Etzioni R, Pepe M, Longton G, Hu C, Goodman G. Incorporating the time dimension in receiver operating characteristic curves: a case study of prostate cancer. Medical Decision Making 1999; 19(3):242-251.
28. Arvesen JN. Jackknifing U-statistics. Annals of Mathematical Statistics 1969; 40:293-325.
29. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Controlled Clinical Trials 1996; 17:343-346.
30. Herndon JE, Harrell Jr FE. The restricted cubic spline as baseline hazard in the proportional hazards model with step function time-dependent covariables. Statistics in Medicine 1995; 14(19):2119-2129.
31. Aitkin M, Anderson D, Francis B, Hinde J. Statistical Modelling in GLIM. Oxford University Press: New York, 1989.
32. S-PLUS 2000. Guide to Statistics. Data Analysis Products Division, MathSoft: Seattle, WA, 1999.
33. Schemper M, Stare J. Explained variation in survival analysis. Statistics in Medicine 1996; 15(19):1999-2012.
34. Moskowitz CS, Kattan MW. Evaluating the accuracy of a predictive model in survival analysis. Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application, Washington, DC, May 20-21 2004.
35. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Wiley: Chichester, 1995.
36. Harrell Jr FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Statistics in Medicine 1984; 3(2):143-152.
37. Kattan MW. Judging new markers by their ability to improve predictive accuracy. Journal of the National Cancer Institute 2003; 95(9):634-635.